Navigation Links
Mississippi State Board of Pharmacy Backs Down After PCMA Threatens Lawsuit
Date:2/26/2013

WASHINGTON, Feb. 26, 2013 /PRNewswire-USNewswire/ -- Facing a lawsuit alleging violations of federal law, the Mississippi Board of Pharmacy (BoP) reversed course and rescinded a proposed regulation that would have imposed unprecedented – and costly – new fiduciary mandates on pharmacy benefit managers (PBMs), the companies that employers, unions, and state agencies hire to negotiate discounts from drugstores.  Most states, including Mississippi, have traditionally relied upon the State Department of Insurance – not the Board of Pharmacy – to oversee PBMs.

The overreach by the Mississippi BoP and ensuing legal challenge by the Pharmaceutical Care Management Association (PCMA) should give policymakers in other states pause when considering granting sweeping new authority to state boards of pharmacy, the association said today.

"Mississippi is the only state to empower pharmacists on a Board of Pharmacy to regulate those with whom they negotiate and do business," said PCMA President and CEO Mark Merritt . "When Boards of Pharmacy push anti-competitive regulations that violate federal laws, we intend to vigorously challenge them."

Allowing pharmacy boards to regulate PBMs creates a conflict of interest since the Board members are pharmacists – a group which contracts with PBMs and could financially benefit from the policies they set. The Federal Trade Commission warned the Mississippi legislature when it transferred regulatory authority from the Insurance Commission to the Board of Pharmacy that allowing pharmacists to regulate PBMs could "increase pharmaceutical prices and reduce competition" and potentially "facilitate collusion" among pharmacies.

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 215 million Americans.

Follow PCMA on Twitter


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
2. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
3. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
4. TorkLaw Responds to FDA Warning Letter to St. Jude Medical Regarding Defective Heart Device; Now Representing Patients in 15 States
5. Fox News Medical Contributor Explains Study of Side Effects from Prostate-Cancer Treatments
6. United States Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
7. Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars
8. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
9. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
10. Virtual Ports Receives Patent Approvals in the United States and Japan
11. Amgen Backs States Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Applied BioMath ... modeling to drug research and development, today announced ... 2017.  QSP Day 2017 is a day full ... quantitative systems pharmacology (QSP) community. The focus is ... is de-risking and accelerating drug research and development. ...
(Date:3/22/2017)... National Medical Products announced its J-Tip ... Technology contract from Vizient, Inc ., the ... The contract was based on a recommendation of ... this category who serve on one of Vizient,s ... technologies that demonstrate an ability to enhance clinical ...
(Date:3/22/2017)...   Upsher-Smith Laboratories, Inc . (Upsher-Smith) today announced the ... mg and 75 mg, the generic equivalent to Mallinckrodt Pharmaceuticals, ... The clomipramine hydrochloride capsules market had U.S. sales of approximately ... to IMS Health. ... "Upsher-Smith has long been recognized within the pharmaceutical ...
Breaking Medicine Technology:
(Date:3/22/2017)... , ... March 22, 2017 , ... ... assistance and financial consultations to families and business owners in the greater Hampton ... the local American Cancer Society Relay For Life event. , Each year, hundreds ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... financial planning services to regional families and business owners, is joining the Teen ... young people in the area. , A growing number of Oklahoma teens and ...
(Date:3/22/2017)... ... ... Chris Humphrey Insurance Agency, a North Carolina firm offering asset protection services and ... initiating a charity event to raise support for five year old Dillyn, a young ... Friday evening in September 2014. At the time, Dillyn was only four years old, ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... The ... debt ceiling and prevent a default on the federal debt — including the debt ... is a growing concern, ” said TSCL in a letter to House and Senate ...
(Date:3/22/2017)... ... 2017 , ... NYC Chiropractor Dr. Steven Shoshany recently helped host a seminar ... in the U.S. and focused on a new protocol for treating pain. Dr. Shoshany ... New York, and furthermore the first seminar in the country was hosted at his ...
Breaking Medicine News(10 mins):